Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
Recruiting
This study is to see if the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) will help prolong the length of time people with diabetes maintain adherence to glucagon-like peptide 1 (GLP-1/GIP) agonists.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/14/2025
Locations: East Coast Institute for Research, LLC, Jacksonville, Florida
Conditions: Diabetes Mellitus